| 68.01 Delayed Data As of Sep 23 |  -1.87 / -2.68%Today’s Change | 58.21 Today|||52-Week Range 133.74 | -32.52% Year-to-Date |
| Why Is Intercept (ICPT) Down 2.5% Since Last Earnings Report? Sep 06 / Zacks.com - Paid Partner Content |
| Previous close | 69.88 |
| Today’s open | 69.12 |
| Day’s range | 67.83 - 70.73 |
| Volume | 373,011 |
| Average volume (3 months) | 571,073 |
| Market cap | $2.3B |
| Earnings growth (last year) | +24.45% |
| Earnings growth (this year) | +4.50% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +37.30% |
| P/E ratio | NM |
| Price/Sales | 15.96 |
| Price/Book | 108.31 |
| Today’s change | Today’s % change | |
|---|---|---|
| PTLAPortola Pharmaceutic... | -0.79 | -2.60% |
| PTCTPTC Therapeutics Inc | +0.11 | +0.28% |
| FOLDAmicus Therapeutics ... | -0.33 | -3.49% |
| AGIOAgios Pharmaceutical... | +0.30 | +0.83% |
| Next reporting date | October 28, 2019 |
| EPS forecast (this quarter) | -$2.46 |
| Annual revenue (last year) | $179.8M |
| Annual profit (last year) | -$309.2M |
| Net profit margin | -171.99% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Mark E. Pruzanski |
Chief Operating Officer Jerome B. Durso |
Corporate headquarters New York, New York |
